Simon N. Pimstone is Director at Xenon Pharmaceuticals Inc. (XENE). They have made 9 open-market trades across 1 company since 2017, most recently 2023-06-01.
CIK 0001620084
1 open-market purchase totalling $17K since 2017, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XENE | 37,000 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2023-06-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XENE | SELL | 2023-05-30 | 2023-06-01 | $38.83 | $9.0M | +11.4% | -1.3% | +0.4% |
| XENE | SELL | 2023-03-07 | 2023-03-09 | $36.98 | $1.4M | -4.4% | -0.5% | +19.0% |
| XENE | SELL | 2022-08-12 | 2022-08-16 | $38.14 | $10.9M | -0.5% | +5.7% | -7.7% |
| XENE | SELL | 2022-03-08 | 2022-03-08 | $30.80 | $77K | +6.2% | +11.6% | -2.6% |
| XENE | SELL | 2022-03-04 | 2022-03-08 | $29.65 | $2.2M | +6.2% | +11.6% | -2.6% |
| XENE | SELL | 2021-11-15 | 2021-11-16 | $31.33 | $1.1M | -14.3% | -15.6% | -2.1% |
| XENE | SELL | 2020-05-29 | 2020-06-02 | $14.16 | $113K | -6.8% | -0.5% | -5.7% |
| XENE | SELL | 2019-09-20 | 2019-09-24 | $9.51 | $198K | -6.1% | -4.9% | +50.0% |
| XENE | BUY | 2017-08-10 | 2017-08-14 | $2.90 | $17K | +25.0% | +24.0% | -10.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.